Abbott beats The Street in Q2 — upping sales growth forecast
Abbott CEO Robert Ford says the company has now seen two quarters in a row of double-digit organic sales growth in its underlying business.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott CEO Robert Ford says the company has now seen two quarters in a row of double-digit organic sales growth in its underlying business.
Johnson & Johnson (NYSE: JNJ) shares ticked up before the market opened today on second-quarter results that topped the consensus forecast.
Intuitive Surgical (Nasdaq: ISRG) shares took a hit after the market closed today on second-quarter results that beat the consensus forecast.
Philips (NYSE: PHG) announced at the end of last week that it plans to repurchase up to 7.1 million shares.
Surmodics announced today that the FDA granted approval for its SurVeil drug-coated balloon.